Paxman Valuation

Is PAX undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

1/6

Valuation Score 1/6

Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of PAX when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: PAX (SEK67.6) is trading below our estimate of fair value (SEK74.47)

Significantly Below Fair Value: PAX is trading below fair value, but not by a significant amount.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for PAX?

Other financial metrics that can be useful for relative valuation.

The above table shows the n/a ratio for PAX. This is calculated by dividing PAX's market cap by their current preferred multiple.
What is PAX's n/a Ratio?
n/a	0x
n/a	n/a
Market Cap	SEK 1.24b

PAX key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	4.9x
Enterprise Value/EBITDA	24.8x
PEG Ratio	0.9x

Price to Earnings Ratio vs Peers

How does PAX's PE Ratio compare to its peers?

The above table shows the PE ratio for PAX vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PE	Estimated Growth	Market Cap
Peer Average	23.4x
CRAD B C-Rad	17.1x	34.7%	SEK 990.6m
ADDV A ADDvise Group	21.2x	19.2%	SEK 859.7m
STIL Stille	37.1x	36.8%	SEK 1.9b
CARE Careium	18.2x	16.5%	SEK 790.6m
PAX Paxman	43.1x	50.6%	SEK 1.2b

Price-To-Earnings vs Peers: PAX is expensive based on its Price-To-Earnings Ratio (44.9x) compared to the peer average (23.4x).

Price to Earnings Ratio vs Industry

How does PAX's PE Ratio compare vs other companies in the European Medical Equipment Industry?

0 Companies	Price / Earnings	Estimated Growth	Market Cap
Industry Avg.	n/a	32.8%
	n/a	n/a	n/a

Fetching data

0 Companies	Price / Earnings	Estimated Growth	Market Cap
Industry Avg.	n/a	32.8%
	n/a	n/a	n/a

No more companies

Price-To-Earnings vs Industry: PAX is expensive based on its Price-To-Earnings Ratio (44.9x) compared to the European Medical Equipment industry average (30.5x).

Price to Earnings Ratio vs Fair Ratio

What is PAX's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

PAX PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio	43.1x
Fair PE Ratio	39.3x

Price-To-Earnings vs Fair Ratio: PAX is expensive based on its Price-To-Earnings Ratio (44.9x) compared to the estimated Fair Price-To-Earnings Ratio (39.5x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.